Pullen A M, Bill J, Kubo R T, Marrack P, Kappler J W
Howard Hughes Medical Institute, Denver, Colorado.
J Exp Med. 1991 May 1;173(5):1183-92. doi: 10.1084/jem.173.5.1183.
Superantigen bound to major histocompatibility complex (MHC) products have been shown to stimulate T cells in a V beta-specific manner. Mouse T cells bearing V beta 8.1 usually respond to the self superantigen, Mls-1a, whereas T cells bearing V beta 8.2a do not. Previously, using site-directed mutational analysis, we identified the residues of natural variants of T cell receptor (TCR) V beta 8.2 that conferred Mls-1a reactivity. These residues are predicted to lie on a beta-pleated sheet of the TCR V beta element, well away from the expected binding site for antigen and MHC proteins. This study was undertaken to determine the effect of glycosylation on this beta-pleated sheet on Mls-1a reactivity and to map the extent of the interaction site on V beta 8.2 for Mls-1a. to Mls-1a, as well as to peptides derived from the conventional protein antigen, chicken ovalbumin. Here we demonstrate that first, N-linked carbohydrate on the lateral surface of V beta blocks the interaction of the TCR V beta with the self superantigen, Mls-1a, but has no effect on the TCR interaction with peptide antigen and MHC, second, that the interaction site for Mls-1a extends over the surface of the solvent-exposed beta-pleated sheet on the side of the TCR, and third, that mutations which affect both superantigen and peptide antigen reactivity lie at the beginning of the first complementarity determining region of V beta, consistent with models of the trimolecular complex of TCR-peptide-MHC.
已证明与主要组织相容性复合体(MHC)产物结合的超抗原以Vβ特异性方式刺激T细胞。携带Vβ8.1的小鼠T细胞通常对自身超抗原Mls-1a有反应,而携带Vβ8.2a的T细胞则无反应。以前,我们利用定点突变分析确定了赋予Mls-1a反应性的T细胞受体(TCR)Vβ8.2天然变体的残基。预计这些残基位于TCR Vβ元件的β折叠片上,远离抗原和MHC蛋白的预期结合位点。本研究旨在确定糖基化对该β折叠片上Mls-1a反应性的影响,并绘制Vβ8.2上与Mls-1a相互作用位点的范围,以及与来自传统蛋白质抗原鸡卵清蛋白的肽段的相互作用范围。在这里我们证明,首先,Vβ侧面的N-连接碳水化合物阻断了TCR Vβ与自身超抗原Mls-1a的相互作用,但对TCR与肽抗原和MHC的相互作用没有影响;其次,Mls-1a的相互作用位点延伸到TCR一侧溶剂暴露的β折叠片表面;第三,影响超抗原和肽抗原反应性的突变位于Vβ第一个互补决定区的起始处,这与TCR-肽-MHC三分子复合物的模型一致。